stage IV esophageal cancer
Showing 51 - 75 of >10,000
Stage I Colorectal Cancer AJCC v8, Stage II Colorectal Cancer AJCC v8, Stage IIA Colorectal Cancer AJCC v8 Trial in San
Completed
- Stage I Colorectal Cancer AJCC v8
- +12 more
- Dietary Intervention
-
San Francisco, CaliforniaZuckerberg San Francisco General Hospital
Jan 5, 2023
Locally Advanced Lung Non-Small Cell Carcinoma, Metastatic Lung Non-Small Cell Carcinoma, Stage II Lung Cancer AJCC v8 Trial in
Recruiting
- Locally Advanced Lung Non-Small Cell Carcinoma
- +12 more
- Computed Tomography
- Contrast Agent
-
New Brunswick, New Jersey
- +1 more
Nov 2, 2022
Liver Metastasis Colon Cancer Trial (IRE plus checkpoint inhibitor, IRE plus Checkpoint Inhibitor plus CpG-ODN)
Not yet recruiting
- Liver Metastasis Colon Cancer
- IRE plus checkpoint inhibitor
- IRE plus Checkpoint Inhibitor plus CpG-ODN
- (no location specified)
Sep 13, 2023
EGFR NP_005219.2:p.S492R, KRAS Gene Mutation, MAP2K1 Gene Mutation Trial in Houston (other, biological, drug)
Recruiting
- EGFR NP_005219.2:p.S492R
- +7 more
- Laboratory Biomarker Analysis
- +2 more
-
Houston, TexasM D Anderson Cancer Center
Dec 5, 2022
Change in Mood, Change in Personality Trial in Haskovo (Undenatured beta-glucan solution, Placebo)
Recruiting
- Change in Mood
- Change in Personality
- Undenatured beta-glucan solution
- Placebo
-
Haskovo, BulgariaCLINECA EAD Hospital
Jul 18, 2023
Advanced Lung Carcinoma, Malignant Female Reproductive System Tumor, Stage III Lung Cancer AJCC v8 Trial in Duarte (Psychosocial
Active, not recruiting
- Advanced Lung Carcinoma
- +6 more
- Psychosocial Care Conquer Fear Support intervention (psychoeducation, attention training, worry management, and detached mindfulness components)
- Questionnaire Administration
-
Duarte, CaliforniaCity of Hope Medical Center
Jan 4, 2023
Metastatic Lung Non-Small Cell Carcinoma, Recurrent Lung Non-Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8 Trial in
Not yet recruiting
- Metastatic Lung Non-Small Cell Carcinoma
- +2 more
- Cetuximab
- +2 more
-
Sacramento, CaliforniaUniversity of California Davis Comprehensive Cancer Center
Oct 2, 2023
HER2-positive Breast Cancer, Stage III Ovarian Epithelial Cancer, Stage III Ovarian Germ Cell Tumor Trial in Seattle
Active, not recruiting
- HER2-positive Breast Cancer
- +8 more
- pNGVL3-hICD vaccine
- +6 more
-
Seattle, WashingtonFred Hutchinson Cancer Research Center/University of Washington
Nov 1, 2022
Clinical Stage III Cutaneous Melanoma AJCC v8, Clinical Stage IV Cutaneous Melanoma AJCC v8 Trial in Shanghai (Endostar,
Recruiting
- Clinical Stage III Cutaneous Melanoma AJCC v8
- Clinical Stage IV Cutaneous Melanoma AJCC v8
-
Shanghai, ChinaFudan University Shanghai Cancer Center
Jun 17, 2023
Breast Cancer, Insomnia Trial (transauricular Vagus Nerve Stimulation)
Not yet recruiting
- Breast Cancer
- Insomnia
- transauricular Vagus Nerve Stimulation
- (no location specified)
Aug 21, 2023
Quality of Life and Utilities Following Surgical Treatment of
Recruiting
- Rectal Adenocarcinoma
- +13 more
- Quality-of-Life Assessment
- Questionnaire Administration
-
Houston, TexasM D Anderson Cancer Center
Oct 11, 2022
Esophageal Cancer, Gastric Cancer Trial in United States (pembrolizumab, trastuzumab, capecitabine)
Active, not recruiting
- Esophageal Cancer
- Gastric Cancer
- pembrolizumab
- +5 more
-
Basking Ridge, New Jersey
- +7 more
Sep 17, 2021
Stage IIB Esophageal Cancer AJCC v7, Stage III Esophageal Cancer AJCC v7, Stage IIIA Esophageal Cancer AJCC v7 Trial
Withdrawn
- Stage IIB Esophageal Cancer AJCC v7
- +4 more
- Ferumoxytol
- Magnetic Resonance Imaging
- (no location specified)
Sep 8, 2021
Appendix Carcinoma by AJCC V8 Stage, Colorectal Carcinoma by AJCC V8 Stage, Digestive System Tumor Trial in New Brunswick
Recruiting
- Appendix Carcinoma by AJCC V8 Stage
- +6 more
- Biospecimen Collection - blood and tissue sample collection
- Electronic Health Record Review
-
Livingston, New Jersey
- +1 more
Nov 16, 2022
Double-dose Furmonertinib in Treatment of Slow
Not yet recruiting
- Non Small Cell Lung Cancer
- +3 more
- (no location specified)
Oct 31, 2023
Stage III Ovarian Cancer, Stage IV Ovarian Cancer, Stage III Primary Peritoneal Cancer Trial (Cisplatin, No treatment)
Not yet recruiting
- Stage III Ovarian Cancer
- +5 more
- Cisplatin
- No treatment
- (no location specified)
Dec 12, 2022
Stage IV NSCLC Trial in Wuhan (SBRT+Osimertinib, Osimertinib 80 MG)
Not yet recruiting
- Stage IV Non-small Cell Lung Cancer
- SBRT+Osimertinib
- Osimertinib 80 MG
-
Wuhan, Hubei, ChinaTongji Hospital Affiliated to Tongji Medical College of Huazhong
Oct 13, 2022
Recurrent Cutaneous Squamous Cell Carcinoma of the Head and Neck, Resectable Cutaneous Squamous Cell Carcinoma of the Head and
Recruiting
- Recurrent Cutaneous Squamous Cell Carcinoma of the Head and Neck
- +4 more
- Cemiplimab
-
Houston, TexasM D Anderson Cancer Center
Jan 17, 2023
Recurrent Lung Non-Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8 Trial (Chemotherapy, Pembrolizumab, Ramucirumab)
Not yet recruiting
- Recurrent Lung Non-Small Cell Carcinoma
- Stage IV Lung Cancer AJCC v8
- Chemotherapy
- +2 more
- (no location specified)
Jan 9, 2023
Esophageal Squamous Cell Carcinoma, Esophageal Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma Trial in Duarte, South
Withdrawn
- Esophageal Squamous Cell Carcinoma
- +2 more
- Epacadostat
- +3 more
-
Duarte, California
- +2 more
Feb 21, 2022
NSCLC Without Mutation in Epidermal Growth Factor Receptor (Disorder) Trial (tereotactic body radiotherapy)
Not yet recruiting
- Non-Small Cell Lung Cancer Without Mutation in Epidermal Growth Factor Receptor (Disorder)
- tereotactic body radiotherapy
- (no location specified)
Dec 1, 2023
Caregiver, Malignant Head and Neck Tumor, Paranasal Sinus Squamous Cell Carcinoma Trial in Winston-Salem (Communication
Completed
- Caregiver
- +37 more
- Communication Intervention
- +5 more
-
Winston-Salem, North CarolinaComprehensive Cancer Center of Wake Forest University
Dec 14, 2022
Metastatic Esophageal Adenocarcinoma, Metastatic Esophageal Squamous Cell Carcinoma, Metastatic Gastroesophageal Junction
Active, not recruiting
- Metastatic Esophageal Adenocarcinoma
- +7 more
- Cixutumumab
- +3 more
-
Scottsdale, Arizona
- +232 more
Nov 16, 2022
Metastatic Malignant Tumor in the Bone, Stage IV Breast Cancer AJCC v6 and v7, Triple-Negative Breast Carcinoma Trial in
Active, not recruiting
- Metastatic Malignant Neoplasm in the Bone
- +2 more
- Laboratory Biomarker Analysis
- +2 more
-
Scottsdale, ArizonaMayo Clinic in Arizona
Jan 4, 2023